{"id":1147,"date":"2021-06-06T20:57:13","date_gmt":"2021-06-06T18:57:13","guid":{"rendered":"https:\/\/imi-pharma.com\/?page_id=1147"},"modified":"2021-06-15T11:10:39","modified_gmt":"2021-06-15T09:10:39","slug":"fertilitet","status":"publish","type":"page","link":"https:\/\/imi-pharma.com\/english\/?page_id=1147","title":{"rendered":"Fertilitet"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;1\/2&#8243;][vc_custom_heading text=&#8221;FERTILITETI&#8221;][vc_column_text]<\/p>\n<p style=\"text-align: justify;\">Infertiliteti prek miliona \u00e7ifte n\u00eb t\u00eb gjith\u00eb bot\u00ebn. Organizata Bot\u00ebrore e Sh\u00ebndet\u00ebsis\u00eb (OBSH) e p\u00ebrkufizon at\u00eb si d\u00ebshtimin p\u00ebr t\u00eb arritur shtatz\u00ebnin\u00eb pas 12 muajsh ose m\u00eb shum\u00eb t\u00eb p\u00ebrpjekjes p\u00ebr t\u00eb mbarsur pa p\u00ebrdorur kontraceptiv\u00eb. P\u00ebr grat\u00eb mbi 35 vje\u00e7, nj\u00eb \u00e7ift duhet t\u00eb vizitoj\u00eb nj\u00eb mjek pasi t\u00eb p\u00ebrpiqet t\u00eb mbetet me barr\u00eb p\u00ebr gjasht\u00eb muaj.<\/p>\n<p style=\"text-align: justify;\">Q\u00ebllimi kryesor i Merck \u00ebsht\u00eb t\u00eb rris\u00eb nd\u00ebrgjegj\u00ebsimin p\u00ebr infertilitetin dhe t\u00eb p\u00ebrmir\u00ebsoj\u00eb m\u00eb tej opsionet e trajtimeve.<\/p>\n<p style=\"text-align: justify;\">Me portofolin ton\u00eb t\u00eb gjer\u00eb t\u00eb opsioneve t\u00eb trajtimit, ne synojm\u00eb t\u00eb kontribuojm\u00eb n\u00eb rezultate t\u00eb p\u00ebrmir\u00ebsuara t\u00eb trajtimit q\u00eb ndihmojn\u00eb \u00e7iftet t\u00eb p\u00ebrmbushin \u00ebndrr\u00ebn e prind\u00ebrimit.<\/p>\n<p style=\"text-align: justify;\">Merck i kushtohet trajtimit t\u00eb pjelloris\u00eb nga zhvillimi i vez\u00ebs deri n\u00eb fazat e hershme t\u00eb shtatz\u00ebnis\u00eb.<\/p>\n<p style=\"text-align: justify;\">Ne jemi lider n\u00eb tregun bot\u00ebror n\u00eb trajtimet e pjelloris\u00eb dhe e vetmja kompani q\u00eb ofron versione rekombinante t\u00eb hormoneve natyrore.<\/p>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_custom_heading text=&#8221;FERTILITY&#8221;][vc_column_text]<\/p>\n<p style=\"text-align: justify;\">Infertility affects millions of couples worldwide. The World Health Organization (WHO) defines it as the failure to achieve pregnancy after 12 months or more of trying to conceive without using contraceptives. For women over 35, a couple should see a doctor after trying to conceive for six months.<\/p>\n<p style=\"text-align: justify;\">The main goal of Merck is to increase awareness of infertility and further improve options of treatments.<\/p>\n<p style=\"text-align: justify;\">With our broad portfolio of treatment options, we aim to contribute to improved treatment outcomes that help couples fulfill the dream of parenthood.<\/p>\n<p style=\"text-align: justify;\">Merck is dedicated to the treatment of fertility from the development of the egg to the early stages of pregnancy.<\/p>\n<p style=\"text-align: justify;\">We are world market leader in fertility treatments and the only company to offer recombinant versions of the natural hormones.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][home_blog style=&#8221;grid&#8221; posts_per_page=&#8221;25&#8243; dynamic_from_where=&#8221;cat&#8221; dynamic_cat=&#8221;15&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;1\/2&#8243;][vc_custom_heading text=&#8221;FERTILITETI&#8221;][vc_column_text] Infertiliteti prek miliona \u00e7ifte n\u00eb t\u00eb gjith\u00eb bot\u00ebn. Organizata Bot\u00ebrore e Sh\u00ebndet\u00ebsis\u00eb (OBSH) e p\u00ebrkufizon at\u00eb si d\u00ebshtimin p\u00ebr t\u00eb arritur shtatz\u00ebnin\u00eb pas 12 muajsh ose m\u00eb shum\u00eb t\u00eb p\u00ebrpjekjes p\u00ebr t\u00eb mbarsur pa p\u00ebrdorur kontraceptiv\u00eb. P\u00ebr grat\u00eb mbi 35 vje\u00e7, nj\u00eb \u00e7ift duhet t\u00eb vizitoj\u00eb nj\u00eb mjek pasi t\u00eb p\u00ebrpiqet t\u00eb [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1147","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages\/1147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1147"}],"version-history":[{"count":3,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages\/1147\/revisions"}],"predecessor-version":[{"id":1377,"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=\/wp\/v2\/pages\/1147\/revisions\/1377"}],"wp:attachment":[{"href":"https:\/\/imi-pharma.com\/english\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}